Sanaria is now preparing to ask the United States Food and Drug Administration for approval to begin federal testing of the vaccine.

VOA: special.2010.04.20

The fact of the matter is that the pre-approval testing of drugs in the 1980s was far less vigorous than what now happens.

FORBES: Why David Healy Is Wrong About the Safety of New Medicines

Merck is setting a good example by evaluating the drug in steps, carefully assessing its effect on patients, and not proceeding toward approval before testing the effect of the drug on patient outcomes in a large study.

FORBES: Merck Does The Right Thing

The idea is to avoid cumbersome double-testing and approval procedures by both sides.

ECONOMIST: Europe and America